SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is seeing renewed engagement as investors speculate on potential M&A moves and monitor Michael Burrys increased stake in the company. The community remains divided, with some users pushing for a 'No' vote on the CEO's compensation package while others focus on long-term value and potential short-squeeze dynamics.

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies is attracting significant investor interest as the community anticipates major catalysts, specifically the finalization of the crypto.com/us partnership and upcoming product launches in the U.S. prediction market space. While bulls highlight high insider ownership and potential for a breakout, active discussions remain divided between those viewing the recent price consolidation as a strategic buying opportunity and skeptics concerned about the timeline for definitive news and regulatory hurdles.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is trending after the company announced the immediate termination of its standby equity purchase agreement with Yorkville, a move long-awaited by investors concerned about potential dilution. The community is actively debating the significance of this development, with bulls viewing it as a critical catalyst for a trend reversal and potential short squeeze, while some remain cautious about the stock's long-term recovery.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is experiencing significant volatility and community debate as investors weigh speculative growth against intensifying competition and geopolitical pressures. While bulls highlight recent DARPA contracts, photonic interconnect milestones, and long-term quantum infrastructure potential as key catalysts, others caution against current valuation levels and macro headwinds impacting the broader tech sector.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing heavy volume and volatility as investors weigh the potential impact of Amazon's acquisition of Globalstar against the upcoming launch of the BlueBird 7 satellite on Blue Origins New Glenn rocket. The community remains deeply divided, with bulls pointing to the company's patented D2D technology and strategic institutional backing as key long-term catalysts, while skeptics focus on competitive pressure and the market's recent reaction to broader sector news.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is experiencing significant downward pressure as investors react to underwhelming delivery figures and ongoing operational challenges, including supply chain disruptions and product recalls. Despite a new buy rating from Citigroup, the community remains deeply divided, with many participants expressing concerns over potential further share dilution and the company's long-term financial viability.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is currently a focal point for investors as its fuel cell technology becomes central to the AI data center infrastructure race, causing significant price volatility and heavy trading volume. The community is actively debating the stock's long-term potential as a critical power provider versus concerns about valuation, recent analyst target adjustments, and the broader impact of energy sector headlines.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense market activity as rumors of an acquisition by Amazon or SpaceX to bolster satellite broadband capabilities drive widespread speculation. Community sentiment is overwhelmingly bullish, with long-term shareholders debating the massive strategic value of the company's globally harmonized spectrum and the complexities surrounding existing partnerships, leading many to dismiss current price valuations as far below the potential bidding war floor.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is generating significant debate as investors weigh the company's dual-platform capabilities and defense sector partnerships against intense competitive pressure from industry heavyweights. The community remains polarized, with many retail traders actively discussing the potential for a rebound driven by institutional accumulation while critics point to concerns over valuation and the company's path to profitability.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is experiencing extreme volatility as retail investors and algorithms react to a mix of aggressive short-interest, speculative trading in the quantum sector, and concerns over the company's ability to hit commercial milestones. The community remains deeply polarized, with bulls pointing to long-term sector potential and technical breakthroughs, while bears focus on the disconnect between high valuations and minimal revenue growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Biotech-focused investor Cormorant Asset Management rebuilt its stake above 6% on Tuesday.</li><li>Cormorant disclosed ownership of 4.36 million shares, up from about 2 million shares in October.</li><li>Retail sentiment flipped to ‘extremely bullish’ from ‘extremely bearish’ on Stocktwits, and message volume surged more than 900%.</li></ul>Shares of MoonLake Immunotherapeutics, Inc. jumped 11% on Tuesday, marking the stock’s biggest rally in over a month, after a biotech-focused investment firm rebuilt its stake amid heightened buzz among retail traders speculating a possible takeover.<h2 class="st-heading-2">Cormorant Lifts MoonLake Stake Above 6%</h2>A Schedule 13G filing on Tuesday showed Cormorant Asset Management reported ownership of 4.36 million Class A ordinary shares in MoonLake Immunotherapeutics, representing a 6.1% stake as of Dec. 31, 2025. The stake increased from about 2 million shares, or 3.14%, disclosed in October 2025 filings, after the firm had previously reduced its position below the 5% reporting threshold.Cormorant Asset Management is a biotech-specialised investment management firm with stakes in Praxis Precision Medicines, BridgeBio Oncology Therapeutics, Edgewise Therapeutics, and Metsera, which was acquired last year by Pfizer, among others.According to data from Quiver Quantitative, the firm reported holdings in 43 stocks as of Sept. 30, 2025, with an estimated portfolio value of about $1.45 billion.<h2 class="st-heading-2">FDA Momentum Builds Around Sonelokimab</h2>Earlier this month, the U.S. Food and Drug Administration (FDA) granted Fast Track designation to the company’s lead investigational therapy, Sonelokimab, for moderate-to-severe palmoplantar pustulosis. The company plans to pursue a biologics license application for Sonelokimab in hidradenitis suppurativa in the second half of 2026.Last month, MoonLake said a Type B meeting with the FDA confirmed its clinical evidence strategy for Sonelokimab in hidradenitis suppurativa. Following that update, several brokerages raised price targets or upgraded the stock, though&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/mltx-stock-erases-most-of-2025-loses-wall-street-retail-bets-on-fda-feedback-for-sonelokima/cmU1QhGR471">Goldman Sachs</a> downgraded MoonLake to ‘Sell’ last month, citing “high risk” around approvability in hidradenitis suppurativa.The company is scheduled to host an investor day on Feb. 23, at which it plans to provide updates on the clinical development and regulatory pathway for Sonelokimab across multiple inflammatory disease indications.<h2 class="st-heading-2">Stocktwits Buzz Erupts Around MLTX</h2>On Stocktwits, retail sentiment for MLTX flipped to ‘extremely bullish’ from ‘extremely bearish’ over the past day amid over a 900% surge in 24-hour message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/mltx_ss_png_b0740594f9.webp" alt="mltx ss.png" width="971" height="140"><figcaption>MLTX sentiment and message volume as of February 17 | Source: Stocktwits</figcaption></figure>One user said the Cormorant filing has “fundamentally broken” the short thesis. “Cormorant—who knows the science better than anyone—just admitted the "Bear Thesis" was wrong by buying back in at $12-$16.”<stembedurl>https://stocktwits.com/septrading/message/645184471</stembedurl>Another user said, “I can’t stop thinking that we get a PR of some sort, even a little teaser, PM tomorrow AM” ahead of the company’s investor day.<stembedurl>https://stocktwits.com/BOOPIE2020/message/645177386</stembedurl>A third user said, “I have to say that something may be coming..This price action today was solid coupled with the high after hours volume. Someone is accumulating.”<stembedurl>https://stocktwits.com/TDMF123/message/645174457</stembedurl>A separate user said they were watching for either a buyout announcement or positive regulatory news this week, while another argued MoonLake would need to trade higher before attracting interest from a large pharmaceutical acquirer.<stembedurl>https://stocktwits.com/Warren_8/message/645090086</stembedurl><stembedurl>https://stocktwits.com/Newcar/message/645134185</stembedurl>One user pointed to recent travel activity involving Merck’s corporate jet, hinting at a potential takeover by the big pharma firm and noted multiple trips to Zurich, where MoonLake is headquartered.&nbsp;<stembedurl>https://stocktwits.com/Bigpapa46/message/645006814</stembedurl>MLTX stock has risen 33% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a MoonLake Immunotherapeutics company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

MoonLake Stock Soars As Biotech Fund Reloads, Takeover Chatter Ignites

Optimism also grew around FDA momentum for its palmoplantar pustulosis drug ahead of MoonLake’s Feb. 23 investor day.

Equity

Promising Mid Cap Stocks Worth Watching - November 20th

Direxion Daily TSLA Bull 2X Shares, Metsera, and AltC Acquisition are the three Mid Cap stocks to watch today, according to MarketBeat's stock screener tool. Mid-cap stocks are shares of companies...

Best Medical Stocks To Keep An Eye On - November 20th

Exact Sciences, Metsera, Eli Lilly and Company, UnitedHealth Group, Regeneron Pharmaceuticals, Johnson & Johnson, and Abbott Laboratories are the seven Medical stocks to watch today, according to...

Best Pharmaceutical Stocks To Follow Today - November 20th

Metsera, Eli Lilly and Company, and Regeneron Pharmaceuticals are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of...

Top Mid Cap Stocks To Follow Now - November 19th

Light & Wonder, ProShares UltraPro Short QQQ, Metsera, Direxion Daily TSLA Bull 2X Shares, and AltC Acquisition are the five Mid Cap stocks to watch today, according to MarketBeat's stock screener...

Best Medical Stocks To Watch Now - November 19th

Metsera, Eli Lilly and Company, UnitedHealth Group, Johnson & Johnson, and Boston Scientific are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks...

Best Pharmaceutical Stocks To Follow Today - November 19th

Metsera, Eli Lilly and Company, Pfizer, AbbVie, Regeneron Pharmaceuticals, Novo Nordisk A/S, and AstraZeneca are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock...

Best Value Stocks To Follow Now - November 19th

Invesco QQQ, ProShares UltraPro Short QQQ, Metsera, Boeing, Circle Internet Group, Nebius Group, and CoreWeave are the seven Value stocks to watch today, according to MarketBeat's stock screener...

Mid Cap Stocks To Research - November 18th

ProShares UltraPro Short QQQ, Light & Wonder, Metsera, Direxion Daily TSLA Bull 2X Shares, Ondas, AltC Acquisition, and Rigetti Computing are the seven Mid Cap stocks to watch today, according to...

Top Medical Stocks Worth Watching - November 18th

Metsera, UnitedHealth Group, Eli Lilly and Company, Merck & Co., Inc., and Olema Pharmaceuticals are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical...

Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell on June 29, 2022 and is headquartered in New York, NY.

Metsera Inc.

Start of a real move higher

Dead cat - we retest the lows

Show me the results

Software is bouncing hard today. Is this the start of a sustained recovery or just a dead cat bounce before we retest the lows?

MTSR
Metsera Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MTSR News

MTSRMetsera Inc